Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction.

Da-Un ChungJohannes TauberLukas KaiserAndrea SchlichtingSimon Pecha Christoph R SinningEnida RexhaHermann ReichenspurnerStephan WillemsNils GosauSamer Hakmi

Published in: Pacing and clinical electrophysiology : PACE (2021)

The S-ICD is a safe and effective alternative for patients after TLE with very similar results regarding device performance and postoperative outcome, when compared to patients who underwent de-novo S-ICD implantation.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis